Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma

Oral Oncology

Volumn 45, Issue 9, 2009, Pages 760-765

  Bello, I O ^a   Alanen, K ^b   Slootweg, P J ^c   Salo, T ^a,d  

^a UNIVERSITY OF OULU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alpha smooth muscle actin; Ameloblastic carcinoma; Ameloblastoma; Calponin; Epithelial membrane antigen; Flow cytometry; Image cytometry, Ki 67; p63

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; PROTEIN P63;

ADULT; AGED; AMELOBLASTIC CARCINOMA; AMELOBLASTOMA; ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DNA CONTENT; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; AMELOBLASTOMA; CALCIUM-BINDING PROTEINS; CARCINOMA; FEMALE; FINLAND; FLOW CYTOMETRY; HUMANS; IMAGE CYTOMETRY; KI-67 ANTIGEN; MALE; MANDIBULAR NEOPLASMS; MAXILLARY NEOPLASMS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MUCIN-1; MUSCLE, SMOOTH; NEOPLASM PROTEINS; NETHERLANDS; RETROSPECTIVE STUDIES;

EID: 68949210672     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.11.011     Document Type: Article

References (31)

1. Small I.A., and Waldron C.A. Ameloblastomas of the jaws. Oral Surg Oral Med Oral Pathol 8 (1955) 281-297
2. Meer S., Galpin J.S., Altini M., Coleman H., and Ali H. Proliferating cell nuclear antigen and Ki-67 immunoreactivity in ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 213-221
3. Kumamoto H., and Ooya K. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas. J Oral Pathol Med 35 (2006) 183-189
4. Ong'uti M.N., Cruchley A.T., Howells G.L., and Williams D.M. Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya. Int J Oral Maxillofac Surg 26 (1997) 376-379
5. Jääskeläinen K., Jee K.J., Leivo I., Saloniemi I., Knuutila S., and Heikinheimo K. Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet Cytogenet 136 (2002) 31-37
6. Sandra F., Mitsuyasu T., Nakamura N., Shiratsuchi Y., and Ohishi M. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncol 37 (2001) 193-198
7. van Diest P.J., Brugal G., and Baak J.P.A. Proliferation markers in tumors: interpretation and clinical value. J Clin Pathol 51 (1998) 716-724
8. Müller S., DeRose P.B., and Cohen C. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry. Arch Pathol Lab Med 117 (1993) 1126-1131
9. Roholl P.J., Elbers H.R., Prinsen I., Claessens J.A., and van Unnik J.A. Distribution of actin isoforms in sarcomas: an immunohistochemical study. Human Pathol 21 (1990) 1269-1274
10. Savera A.T., Gown A.M., and Zarbo R.J. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Modern Pathol 10 (1997) 1093-1100
11. Kellermann M.G., Sobral L.M., da Silva S.D., Zecchin K.G., Graner E., Lopes M.A., et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 51 (2007) 849-853
12. Vered M., Shohat I., Buchner A., and Dayan D. Myofibroblasts in stroma of odontogenic cysts and tumors can contribute to variations in the biologic behavior of lesions. Oral Oncol 41 (2005) 1028-1033
13. Funaoka K., Arisue M., Kobayashi I., Iizuka T., Kohgo T., Amemiya A., et al. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma. Eur J Cancer B Oral Oncol 32B (1996) 328-332
14. Bologna-Molina R., Mosqueda-Taylor A., Lopez-Corella E., Almeida O.P., Carrasco-Daza D., Garcia-Vazquez F., et al. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas. Oral Oncol 44 (2008) 805-811
15. Kim J., and Yook J.I. Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Eur J Cancer B Oral Oncol 30B (1994) 126-131
16. Hemmer J., and Kreidler J. Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Comparison with clinical staging and histologic grading. Cancer 66 (1990) 317-320
17. Balsara B.R., Borges A.M., Pradhan S.A., Rajpal R.M., and Bhisey A.N. Flow cytometric DNA analysis of squamous cell carcinomas of the oral cavity: correlation with clinical and histopathological features. Eur J Cancer B Oral Oncol 30B (1994) 98-101
18. Syms III C.A., Eibling D.E., McCoy Jr. J.P., Barnes L., Emanuel B., Fowler C., et al. Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 105 (1995) 149-155
19. Saiz-Bustillo R., Corchero-Martín G., García-Montesinos-Perea B., Gonzalez-Terán T., and Sánchez-Santolino S. Oral squamous cell carcinoma. Cytometric parameters of prognostic interest. Med Oral Patol Oral Cir Bucal 10 (2005) 462-467
20. Alanen K.A., Lintu M., and Joensuu H. Image cytometry of breast carcinomas that are DNA diploid by flow cytometry: time to revise the concept of DNA diploidy?. Anal Quant Cytol Histol 20 (1998) 178-186
21. Susnik B., Poulin N., Phillips D., LeRiche J., and Palcic B. Comparison of DNA measurement performed by flow and image cytometry of embedded breast tissue sections. Anal Quant Cytol Histol 17 (1995) 163-171
22. Baglole C.J., Ray D.M., Bernstein S.H., Feldon S.E., Smith T.J., Sime P.J., et al. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 35 (2006) 297-325
23. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9 (2007) 1392-1400
24. Dhir K., Sciubba J., and Tufano R.P. Ameloblastic carcinoma of the maxilla. Oral Oncol 39 (2003) 736-741
25. Thiery J.P. Epithelial-mesenchymal-transitions in development and pathologies. Curr Opin Cell Biol 15 (2003) 740-746
26. Chaffer C.L., Thompson E.W., and Williams E.D. Mesenchymal-epithelial-transition in development and disease. Cells Tissues Organs 185 (2007) 7-19
27. Xue C., Plieth D., Venkov C., Xu C., and Neilson E.G. The gatekeeper effect of epithelial-mesenchymal-transition regulates the frequency of breast cancer metastasis. Cancer Res 63 (2003) 3386-3394
28. Rosivatz E., Becker I., Specht K., Fricke E., Luber B., Busch R., et al. Differential expression of the epithelial-mesenchymal-transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 161 (2002) 1881-1891
29. Shintani Y., Maeda M., Chaika N., Johnson K.R., and Wheelock M.J. Collagen I promotes epithelial-mesenchymal-transition in lung cancer cells via transforming growth factor-beta signaling. Am J Respir Cell Mol Biol 38 (2008) 95-104
30. Saito T., Nagai M., and Ladanyi M. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal-epithelial-transition in human synovial sarcoma. Cancer Res 66 (2006) 6919-6927
31. Mäki M., and Athanasou N. Osteofibrous dysplasia and adamantinoma: correlation of proto-oncogene product and matrix protein expression. Human Pathol 35 (2004) 69-74